Nocturnal desaturation in cystic fibrosis (CF) may have prognostic implications because a significant and maintained nocturnal desaturation can contribute to the development and progression of pulmonary hypertension with cor pulmonale. Its relation with the desaturation in exercise has not been sufficiently studied. We aimed to determine whether desaturation during 6MWT can be an indicator of nocturnal desaturation in adult subjects with CF.
METHODS:
57 subjects were included: 50.9% male, 27.5 ± 7.7 y old, mean FEV1 = 2.37 ± 0.74 L, and %FEV1 67 ± 18.1%. Desaturation during 6MWT was defined as oxygen saturation (SpO2) ≤ 90% or a decline of > 4 points in SpO2 from baseline, and nocturnal desaturation as a desaturation index > 4 or > 5% of sleep time with SpO2 ≤ 90%.
RESULTS:
Desaturation observed during 6MWT in adult subjects with CF did not correlate with nocturnal desaturation (P = .27). Subjects with %FEV1 ≤ 55% and diffusion capacity of carbon monoxide (DLCO) ≤ 50 mmol/min/mm Hg were at higher risk of 6MWT desaturation. Nocturnal desaturation was more frequent in males, with PaO2 ≤ 71 mm Hg in blood gas analysis.
CONCLUSIONS:
Desaturation observed in 6MWT cannot predict desaturation at night in adults with CF. Other parameters were identified as predictors of desaturation.
SalvatoreD, BuzzettiR, BaldoE, FurnariML, LucidiV, ManunzaD, et al. An overview of international literature from cystic fibrosis registries. Part 4: update 2011. J Cyst Fibros, 2012; 11(6):480–493.
2.
MoralesP, SánchezE. Identificación, estructura y expresión del gen CFTR. In: SalcedoA, GartnerS, GirónRM, GarcíaMD. editors Tratado de Fibrosis Quística. Madrid: Editorial Justim; 2012:29–40.
3.
Cystic Fibrosis Foundation Patient Registry. 2015 Annual Data Report. Bethesda: Maryland; 2016:6–7.
4.
CahalinL, PappagianopoulosP, PrevostS, WainJ, GinnsL. The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease. Chest, 1995; 108(2):452–459.
5.
MartinC, ChapronJ, HubertD, KanaanR, HonoréI, PaillasseurJL, et al. Prognostic value of six minute walk test in cystic fibrosis adults. Respir Med, 2013; 107(12):1881–1887.
6.
BradleyS, SolinP, WilsonJ, JohnsD, WaltersEH, NaughtonMT. Hypoxemia and hypercapnia during exercise and sleep in patients with cystic fibrosis. Chest, 1999; 116(3):647–654.
7.
De Castro-SilvaC, de BruinVM, CavalcanteAG, BittencourtLR, de BruinPF. Nocturnal Hypoxia and Sleep Disturbances in Cystic Fibrosis. Pediatr Pulmonol, 2009; 44(11):1143–1150.
8.
VillaMP, PaganiJ, LucidiV, PalamidesS, RonchettiR. Nocturnal oximetry in infants with cystic fibrosis. Arch Dis Child, 2001; 84(1):50–54.
9.
García HernándezG, Martínez MartínezMT. Protocolo de control y seguimiento. In: SalcedoA, GartnerS, GirónRM, GarcíaMD. eds. Tratado de Fibrosis Quística. Madrid: Editorial Justim; 2012:139–147.
10.
UyanZS, OzdemirN, ErsuR, AkpinarI, KeskinS, CakirE. Factors that correlate with sleep oxygenation in children with cystic fibrosis. Pediatr Pulmonol, 2007; 42(8):712–716.
11.
UrquhartDS, MontgomeryH, JafféA. Assessment of hypoxia in children with cystic fibrosis. Arch Dis Child, 2005; 90(11):1138–1143.
12.
GartnerS, CobosN. Cribado neonatal para la fibrosis quística (editorial). An Pediatr (Barc), 2009; 71(6):481–482.
13.
Barrio Gómez de AgüeroMI, García HernándezG, GartnerS. Cystic Fibrosis Working Group. Protocolo de diagnóstico y seguimiento de los pacientes con fibrosis quística. An Pediatr (Barc), 2009; 71(3):250–264.
14.
SinaasappelM, SternM, LittlewoodJ, WolfeS, SteinkampG, HeijermanHG, et al. Nutrition in patients with cystic fibrosis: a European consensus. J Cyst Fibros, 2002; 1(2):51–75.
15.
ShwachmanH, KulczyckiLL. Long term study of 105 patients with cystic fibrosis. Am J Dis Child, 1958; 96:6–10.
16.
BrasfieldD, HicksG, SoongS, PetersJ, TillerR. Evaluation of scoring system of the chest radiograph in cystic fibrosis: a collaborative study. AJR Am J Roentgenol, 1980; 134(6):1195–1198.
17.
AlbiG, Rayón-AledoJC, CaballeroP, RosadoP, García-EsparzaE. Fibrosis quística en imágenes. Clasificación de Bhalla para la tomografía computarizada en pacientes pediátricos. Radiología, 2012; 54(3):260–268.
18.
QuittnerAL, BuuA, MesserMA, ModiAC, WatrousM. Development and validation of the Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest, 2005; 128(4):2347–2354.
19.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002; 166(1):111–117.
20.
FrangoliasDD, WilcoxPG. Predictability of oxygen desaturation during sleep in patients with cystic fibrosis. Chest, 2001; 119(2):434–441.
21.
SmithDL, FreemanW, CaytonRM, StableforthDE. Nocturnal hypoxemia in CF: relationship to pulmonary function tests. Respir Med, 1994; 88(7):537–539.
22.
MontgomeryM, WiebickeW, BibiH, PagtakhanRD, PasterkampH. Home measurement of oxygen saturation during sleep in patients with cystic fibrosis. Pediatr Pulmonol, 1989; 7(1):29–34.
23.
BraggionC, PradalU, MastellaG. Haemoglobin desaturation during sleep and daytime in patients with cystic fibrosis and severe airway obstruction. Acta Paediatr, 1992; 81(12):1002–1006.
24.
VersteeghFG, BogaardJM, RaatgeverJW, StamH, NeijensHJ, KerrebijnKF. Relationship between airway obstruction, desaturation during exercise and nocturnal hypoxemia in cystic fibrosis patients. Eur Resp J, 1990; 3(1):68–73.
25.
CoffeyMJ, FitzgeraldMX, McNicholasWT. Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis. Chest, 1991; 100(3):659–662.
26.
Van der GiessenL, BakkerM, JoostenK, HopW, TiddensH. Nocturnal oxygen saturation in children with stable cystic fibrosis. Pediatr Pulmonol, 2012; 47(11):1123–1130.
27.
AmannM. Pulmonary system limitations to endurance exercise performance in humans. Exp Physiol, 2012; 97(3):311–318.
28.
GruetM, BrisswalterJ, MelyL, VallierJM. Use of the peak heart rate reached during six-minute walk test to predict individualized training intensity in patients with cystic fibrosis: validity and reliability. Arch Phys Med Rehabil, 2010; 91(4):602–607.
29.
ChettaA, PisiG, ZaniniA, ForesiA, GrzincichGL, AielloM, et al. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects. Respir Med, 2001; 95(12):986–991.
30.
OkuroRT, Oliveira RibeiroMA, RibeiroJD, MinskyRC, SchivinskiCI. Alternative indexes to estimate the functional capacity from the 6-minute walk test in children and adolescents with cystic fibrosis. Respir Care, 2017; 62(3):324–332.
31.
GrosboisJM, RiquierC, ChehereB, CoquartJ, BéhalH, BartF, et al. Six-minute stepper test: a valid clinical exercise tolerance test for COPD patients. Int J Chron Obstruct Pulmon Dis, 2016; 11:657–663.
32.
CoquartJB, LemaîtreF, CastresI, SaisonS, BartF, GrosboisJM. Reproducibility and sensitivity of the 6-minute stepper test in patients with COPD. COPD, 2015; 12(5):533–538.
33.
ZinmanR, CoreyM, CoatesAL, CannyGJ, ConnollyJ, LevisonH, et al. Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients. J Pediatr, 1989; 114(3):368–677.
